Feature
Enterprise year in review
Innovation and entrepreneurship at Imperial: A year in review
Imperial’s enterprising ecosystem has flourished in 2022.
Stories written by David Silverman
Microbiome medicine
Imperial partnering with EnteroBiotix to advance microbiome medical treatments
Imperial is partnering with biotechnology company EnteroBiotix on research into the potential of therapies based on the gut bacterial community.
Automating R&D
Machine learning techniques from Imperial and BASF advance experimental design
Imperial and chemical company BASF will reveal new techniques for optimising experimental design at leading machine learning conference NeurIPS.
1
Boosting nanoparticle R&D
New startup to help pharmaceutical companies develop nanoparticle medicines
Imperial startup SPARTA Biodiscovery is offering technology to accelerate the development and production of nanoparticles used in advanced medicines.
2
Your face in 3D
Imperial startup to bring Hollywood-style 3D face capture to consumers
Technology from Lumirithmic based on Imperial research can create a life-like digital model of a person’s face in minutes.
1
Synthetic biology centre
National hub to support synthetic biology extended with £5.5m funding commitment
SynbiCITE, the UK’s National Centre for the Industrial Translation of Synthetic Biology, has received a £5.5m funding commitment from SynBioVen.
1
Sustainable chemicals
Imperial and BASF in major partnership to advance future of chemical production
Imperial and BASF, the world’s largest chemical producer, have begun a new phase in their strategic partnership to advance modern chemical production.
Analytical science
Analytical science facility celebrates progress in materials, medicine and more
The Agilent Measurement Suite, a flagship analytical science facility at the White City Campus, is celebrating three years since it opened its doors.
Video
Mind-controlled VR
New video from Imperial startup shows VR game controlled by thought
A new video by Imperial startup Cogitat shows a VR game-player controlling their virtual body using nothing more than the power of thought.
1
Immunotherapy accelerated
New device could accelerate the development of T-cell immunotherapies for cancer
Imperial researchers have invented a device that can rapidly select T-cells that are most effective at attacking cancer cells.
